Search

everythinglearnresearchcommunity

for

Search:↓

The Li-Pa/Ca and Do/Ca chemotherapy regimens for serous ovarian cancer showed better short-term and long-term results than the Pa/Ca regimen.

CTE can distort results in hair growth trials, so exclude it carefully.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

Researchers created a simple tool to predict bladder blockage from prostate enlargement using urine flow rate and prostate volume.

Researchers developed a reliable method to measure testosterone and epitestosterone in urine for medical and anti-doping use.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

The Modified Wash Test is reliable for diagnosing hair loss conditions and determining treatment priority.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

High-dose vitamin A was safe and well-tolerated in a lung cancer treatment study.

Tiger tail banding and hair abnormalities are reliable indicators for diagnosing trichothiodystrophy.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

The Greek DCQ is a reliable and valid tool for assessing dysmorphic concern.

Trichoscopy is highly effective for diagnosing scalp disorders and should be used more in dermatology.

The study suggests using a score of 11 on the mFG scale to diagnose hirsutism in Turkish women, with adjustments for age, skin type, and family history.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Tadalafil and Finasteride may help treat aggressive melanoma.

Stopping erlotinib improved severe hair loss and skin issues in a patient.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

The care model improved timely diagnosis and treatment for psoriasis and psoriatic arthritis.

Cutaneous lupus erythematosus greatly reduces patients' quality of life.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

Treatment with 5α-reductase inhibitors is linked to a delay in prostate cancer diagnosis and may affect survival rates.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Troxerutin helps protect skin cells from oxidative stress and may be good for treating hair loss.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

Nested PCR can reliably identify fungal infections when traditional methods fail.